Opposing actions of angiotensin II on microvascular growth and arterial blood pressure

Hypertension
Diane H Munzenmaier, Andrew S Greene

Abstract

We performed studies to further elucidate the mechanisms of angiotensin II (Ang II)-induced angiogenesis of the microvasculature. Rats were placed on a high salt diet (4% NaCl), and Ang II was infused at a subpressor rate (5 ng/kg per minute) for 3 days. Blood pressure was measured daily for 2 control and 3 infusion days. Microvessel density in the cremaster muscle was measured at the end of the infusion. Vessel density in rats that received subpressor Ang II infusion increased by 12.6% compared with rats that received vehicle infusion. When the angiotensin type 2 (AT2) receptor antagonist PD 123319 was coinfused with Ang II, blood pressure was elevated and vessel density increased above that observed with Ang II infusion alone (23% increase). When the AT1 receptor antagonist losartan was coinfused with Ang II, blood pressure was lower than control and vessel density was reduced compared with the Ang II group but was still greater than control (7.8% increase). In this study, Ang II stimulated angiogenesis in the rat cremaster muscle; this effect was enhanced by AT2 antagonism and inhibited by AT1 antagonism. Ang II infusion at a subpressor dose resulted in a pressor response with AT2 antagonism and a depressor response with AT1...Continue Reading

References

Sep 30, 1991·Biochemical and Biophysical Research Communications·M ViswanathanJ M Saavedra
Jun 1, 1990·The American Journal of Physiology·R L HaberlK M Einhäupl
May 1, 1985·Hypertension·J NussbergerH R Brunner
Oct 1, 1981·Experimental and Molecular Pathology·M Campbell-Boswell, A L Robertson
Mar 1, 1995·Microvascular Research·M J RiederA S Greene

❮ Previous
Next ❯

Citations

Oct 3, 1999·Cell Biochemistry and Biophysics·D H Wang, F Elijovich
Jan 15, 2009·Acta Neuropathologica·Heike Beck, Karl H Plate
Dec 21, 2004·Angiogenesis·David C SaneK Bridget Brosnihan
Jun 11, 2008·Molecular and Cellular Biochemistry·Tatsuo TaniMasaaki Tamura
Jan 16, 2002·Current Hypertension Reports·Andrew S Greene, Sandra L Amaral
Mar 11, 2004·Current Hypertension Reports·Ruth E Hannan, Robert E Widdop
Apr 6, 2004·Molecular and Cellular Endocrinology·Karen J Greenland, Amal K Mukhopadhyay
Feb 11, 2004·Progress in Biophysics and Molecular Biology·Tara A CollidgeJohn J Mullins
Jul 4, 2001·Biochemical Pharmacology·J AchardL A Fernandez
Oct 21, 2000·European Journal of Pharmacology·B D HegartyE R Lumbers
May 4, 1999·European Journal of Pharmacology·E A KalkmanR G Schoemaker
Sep 9, 1999·European Journal of Pharmacology·J R McMullenJ Wu
Jun 27, 2003·Microvascular Research·Barbara CresciEnrico Magg
Jun 1, 2001·Regulatory Peptides·M Stoll, T Unger
Jul 8, 1999·Regulatory Peptides·M de Gasparo, H M Siragy
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Christiane PeesPeter Gohlke
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Alun Jones, David R Woods
Sep 28, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shigang LiZhice Xu
Jan 12, 1999·British Journal of Pharmacology·A S ZwartR E Widdop
Oct 13, 2000·British Journal of Pharmacology·H Y SohnU Pohl
Jan 12, 2002·British Journal of Pharmacology·Costanza EmanueliPaolo Maddeddu
Feb 14, 2002·Kidney International·Robert F ChouinardKatherine R Tuttle
Oct 2, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Flávia Fernandes MesquitaPatrícia Aline Boer
Feb 24, 1999·Journal of Cardiovascular Pharmacology·U Stroth, T Unger
Dec 22, 1999·Journal of Cardiovascular Pharmacology·J H BurrellC Bernasconi
Apr 26, 2002·Journal of Cardiovascular Pharmacology·Carlos F SantosAndrew S Greene
Feb 27, 2001·Current Opinion in Nephrology and Hypertension·A BlumeT Unger
Dec 20, 2007·Journal of Cardiovascular Pharmacology·Hoang ThaiMohamed A Gaballa
Apr 29, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Micheline M de Resende, Andrew S Greene
Feb 28, 2009·Circulation Research·Yajaira Suárez, William C Sessa
Oct 8, 1999·The Journal of Clinical Investigation·Y TsutsumiT Iwasaka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Microcirculation : the Official Journal of the Microcirculatory Society, Inc
Sandra L AmaralAndrew S Greene
Microcirculation : the Official Journal of the Microcirculatory Society, Inc
Matthew C Petersen, Andrew S Greene
© 2021 Meta ULC. All rights reserved